RaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
Market Rules
Scientists at Rani Therapeutics in California (USA) developed a pill called RaniPill to replace painful injections of drugs that cannot be taken orally. This is interesting because painful treatments reduce patient compliance, which can be harmful to health.
The pill passes through the stomach and arrives intact in the intestine, where it dissolves. A small balloon is then inflated and punctures a tiny needle in the intestine, injecting the substance that is carried by the pill. The balloon with the needle then deflates and is then evacuated.
Human tests for the pill were performed in Australia in 2019, where patients did not report any discomfort, and the pill's effectiveness was the same as a conventional injection. The company responsible for the pill continues to run tests and trials, aimed at receiving the FDA approval for commercializing the pill as a substitute for injections.
If RaniPill is approved for sale by December 31, 2026, this market will resolve to "Yes".